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Abstract
Background: Congenital lactase deficiency is an extremely rare gastrointestinal disorder characterized by neonatal-onset
watery diarrhoea and failure to thrive. We present the first genetically confirmed case of congenital lactase deficiency in
Central Europe.
Case presentation: After an uneventful pregnancy and birth, a male newborn of consanguineous parents of Turkish
origin presented with watery diarrhoea. On day 17, he was admitted to hospital with weight loss, hypertonic dehydration,
and metabolic acidosis. Additionally, the patient showed an elevated calcium concentration in blood and urine as well as
nephrocalcinosis. Diarrhoea stopped during intravenous rehydration and when feeding a glucose-, galactose-, and
lactose-free formula. Therefore, glucose-galactose-malabsorption was assumed. However, genetic testing of the SGLT1
(SLC5A1) gene was negative and, indeed, feeding maltodextrine did not result in recurrence of diarrhoea. In contrast,
lactose feeding immediately caused watery diarrhoea, suggesting congenital lactase deficiency. Genetic testing of the LCT
gene revealed homozygosity for a 1-bp deletion in exon 8 (c.3448delT). Because of the nature of the mutation, causing a
frame shift and a premature termination of translation, congenital lactase deficiency was confirmed and intestinal biopsies
were unnecessary. The patient’s general condition improved substantially on a lactose-free diet, including hypercalcaemia,
hypercalciuria, and nephrocalcinosis which, however, only disappeared after months.
Conclusion: This case demonstrates (a) that congenital lactase deficiency should be considered in cases of severe
neonatal diarrhoea, (b) that intestinal biopsies can be avoided in typical cases that are confirmed by genetic testing, and
(c) that the associated nephrocalcinosis can be reversed on diet and an appropriate fluid management.
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Background
Congenital lactase deficiency (CLD, OMIM #223000) is a
rare but severe gastrointestinal disorder. Characteristic
symptoms are osmotic diarrhoea with subsequent dehydra-
tion and loss of weight despite adequate caloric intake.
Symptoms begin during the first week of life due to the in-
gestion of lactose-containing breast milk or formula. First
descriptions of CLD date back to the late 1950s [1, 2]. CLD
is caused by a deficiency of intestinal lactase activity (EC
3.2.1.23) which is the result of mutations of the lactase-
phlorizin hydrolase gene (LCT) whose 49.3 kb of genomic
DNA organized in 17 exons are located on 2q21.3 [3–5]. In
Finland, a single LCT mutation is highly prevalent (carrier
frequency 1/35) with the result that this autosomal-
recessive disorder is relatively frequent there. A total of
seven different LCT mutations have been described so far
in Finnish patients [4, 6]. Recently, the first mutations of
patients from outside Finland have been found [6, 7]. We
present the first genetically confirmed case of congenital
lactase deficiency diagnosed in Central Europe based upon
detection of a novel mutation within the LCT gene.
Case presentation
We present the case of a male newborn of consanguineous
parents of Turkish origin living in Germany. Family history
was unremarkable, particularly cases of neonatal diarrhoea
or unexplained death shortly after birth were not observed.
The child was born at term with a weight of 3380 g. He
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developed 12–15 watery stools per day after breast feeding
was started. He was admitted to hospital on postnatal day
17 with a weight loss of 14 % as compared to birth weight
and with signs of hypertonic dehydration (Na+ 152 mmol/l)
and metabolic acidosis (pH 7,29; base excess −11,4 mmol/l,
HCO3
− 13,6 mmol/l, pCO2 29 mmHg). Highly elevated cal-
cium concentrations were measured in blood (4,02 mmol/l)
and urine (10,5 mmol/l) and an ultrasound examination of
the abdomen showed nephrocalcinosis and, later in the
course, nephrolithiasis (Fig. 1).
Intravenous rehydration was started immediately and a
glucose-, galactose-, and lactose-free formula was fed. The
diarrhoea stopped and the patient’s general condition
improved substantially. Therefore, glucose-galactose-
malabsorption (GGM) was assumed. However, genetic
testing of SGLT1 (SLC5A1) was negative and, as expected,
oral ingestion of maltodextrine did not provoke diarrhoea.
Once the patient was fed with lactose, however, he im-
mediately developed watery diarrhoea again, suggesting
congenital lactase deficiency. Invasive measures, such as
an intestinal biopsy in order to measure lactase activity,
were not performed since we saw a dramatic improve-
ment on a lactose-free diet. Instead, genetic testing of
the lactase-phlorizin hydrolase gene (LCT) was per-
formed revealing homozygosity for a 1-bp deletion in
exon 8 (c.3448delT). This mutation predicts a frameshift
and a premature termination of translation of the lactase
pre-pro-protein (p.S1150Pfs*19) (Fig. 2).
After a lactose-free diet had been introduced and
diarrhoea had subsided, the patient gained weight and
his psychomotor development was normal. Importantly,
hypercalcaemia and hypercalciuria disappeared only within
months. Nephrocalcinosis improved slowly, however, sev-
eral calcium oxalate stones came off with severe pain at-
tacks and, eventually, a last prevesical stone was removed
endoscopically at an age of 17 months.
Discussion
Based on the detection of a novel mutation within the
LCT gene, we present the first genetically confirmed case
of congenital lactase deficiency (CLD) diagnosed in Cen-
tral Europe. This mutation has not been described in the
literature so far but according to its nature, there is no
doubt that it is disease-causing. In our patient, we found
a small deletion which predicts a frame shift and a trun-
cated protein with loss of the active site, and it is well
conceivable that this will alter trafficking to the brush
border membrane as already shown for other truncating
LCT mutations [8]. This is only the third report of LCT
mutations from outside Finland (Table 1). The first pub-
lication on an Italian patient and Turkish siblings [4]
was followed by a single compound heterozygous patient
from Japan [7, 9]. The fact that this is the very first re-
port on a genetic defect of LCT from Central Europe, a
region with a traditional interest in this condition [10],
confirms that CLD is really rarely encountered here, def-
initely with a frequency much lower than 1:60,000 as es-
timated for Finland [3].
In the past, intestinal biopsies had to be investigated in
such cases in order to confirm the suspected diagnosis. Al-
though these biopsies had to be gained via gastroduodeno-
scopy, an invasive and cost-intensive measure, the gold
standard of diagnosis in case of suspected CLD was the
Dahlquist method [11] measuring the lactase activity within
an intestinal specimen. Our case emphasizes that intestinal
biopsies are no longer needed in most patients in whom
CLD is suspected. The symptoms of CLD are consistent
and can easily be provoked by lactose ingestion; thus, pa-
tients with CLD can be reliably selected by a concise clin-
ical investigation. Genetic testing for mutations of the LCT
gene rather than intestinal enzymatic studies (or even H2
malabsorption studies) should be performed whenever
CLD is suspected in patients with typical symptoms and a
positive resoponse to dietary elimination of lactose. The re-
sult of a genetic test describes the basic defect and excludes
secondary effects; thus, it is more reliable for genetic coun-
seling and for family planning. This test should be used
generously in suspicious cases since Torniainen et al. con-




Fig. 1 Nephrocalcinosis. Ultrasound of left (a) and right (b) kidney at
time of admission to the hospital. Note parenchymal densities partly
accompanied by dorsal echo extinction
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prevalence of CLD might be higher than assumed [6]. As
CLD is a severe disease that can easily be treated by dietary
means once the correct diagnosis is established, genetic
testing for CLD should be considered early by gastroenter-
ologists, neonatologists and paediatricians.
Also we found that CLD is associated with nephrocalci-
nosis as described previously. Thus, our observation is in
line with the report of Saarela et al. [12] describing hyper-
calcaemia already at the time of diagnosis of CLD. Calcium
concentrations in blood and excretion with urine normal-
ized only within months after the correction of dehydration
and beginning of a lactose-free diet in our case. Our case
also confirms that it may take years until problems of
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Fig. 2 Novel mutation of the LCT gene. Results of DNA sequencing of a PCR product containing exon 8 of the LCT gene. Presented are chromatographs
of the patient, both parents, and a control. Depicted is the region of codon 1150 demonstrating homozygosity for a 1-bp deletion in the patient. Both
parents show a heterozygous pattern for this mutation. wt, wild-type sequence; mut, mutated sequence
Table 1 Reported patients with LCT mutations
pt # ethnic origin exon mutation mutation effect c
Kuokkanen 2006 [4] 1–27 Finland homozygous ex09 c.4170T > A p.Y1390* nonsense (truncating)
28–29 Finland compound heterozygous a ex14 c.4998_5001delTGAG p.S1666Kfs*58 fs (truncating)
30 Finland compound heterozygous a ex02 c.653_654delCT p.S218Cfs*6 fs (truncating)
31 Finland compound heterozygous a ex03 c.804G > C p.Q268H missense
32 Finland compound heterozygous a ex09 c.4087G > A p.G1363S missense
Torniainen 2009 [6]
33 Italian
compound heterozygous ex07 c.2062T > C p.S688P missense
compound heterozygous ex12 c.4834G > T p.E1612* nonsense (truncating)
34 Finland compound heterozygous a ex06 c.1692_1696delAGTGG p.V565Lfs*3 fs (truncating)
35 Finland compound heterozygous a ex12 c.4760G > A p.R1587H missense
36 Turkish b homozygous ex09 c.4087G > A p.G1363S missense
Uchida 2012 [7]
37 Japanese
compound heterozygous ex10 c.4419C > G p.Y1473* nonsense (truncating)
compound heterozygous ex16 c.5387delA p.D1796Afs*18 fs (truncating)
This study 2015 38 Turkish homozygous ex08 c.3448delT p.S1150Pfs*19 fs (truncating)
a compound heterozygosity with c.4170 T > A; b two siblings; c fs, frameshift and premature stop (*) of translation
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Nephrocalcinosis can be due to dehydration and due to
chronic metabolic acidosis as it has been described in the
context of glucose-galactose-malabsorption [13]. The
complete pathogenesis of nephrocalcinosis in CLD has yet
remained unclear.
Conclusions
This case demonstrates (a) that congenital lactase defi-
ciency should be considered in cases of severe neonatal-
onset diarrhoea, (b) that in typical cases, responding to
lactose elimination from the diet, intestinal biopsies are
not the first-line diagnostic steps and should be replaced
by genetic testing, and (c) that the associated nephrocal-
cinosis can be a long-lasting problem despite appropriate
rehydration and dietary measures.
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